menu
    • menu
    [{"orgOrder":0,"company":"DSE Healthcare Solutions","sponsor":"DSE Healthcare Solutions","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"U.S.A","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Charcocaps","moa":"Undisclosed","graph1":"Gastroenterology","graph2":"Undisclosed","graph3":"DSE Healthcare Solutions","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"DSE Healthcare Solutions \/ DSE Healthcare Solutions","highestDevelopmentStatusID":"1","companyTruncated":"DSE Healthcare Solutions \/ DSE Healthcare Solutions"},{"orgOrder":0,"company":"DSE Healthcare Solutions","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"U.S.A","productType":"Miscellaneous","year":"2020","type":"Inapplicable","leadProduct":"Paracetamol","moa":"||Anandamide amidohydrolase | Cyclooxygenase | Vanilloid receptor","graph1":"Neurology","graph2":"Approved FDF","graph3":"DSE Healthcare Solutions","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Tablet","sponsorNew":"DSE Healthcare Solutions \/ Undisclosed","highestDevelopmentStatusID":"15","companyTruncated":"DSE Healthcare Solutions \/ Undisclosed"}]

    Find Clinical Drug Pipeline Developments & Deals by DSE Healthcare Solutions

    Menu

    DSE Healthcare Solutions

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            DSE Healthcare Solutions

                            U.S.A arrow
                            SupplySide West
                            Not Confirmed

                            DSE Healthcare Solutions

                            U.S.A arrow
                            SupplySide West
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Charcocaps

                            Therapeutic Area : Gastroenterology

                            Study Phase : Undisclosed

                            Recipient : University of Memphis

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effects of CharcoCaps® (Activated Charcoal) vs. Placebo on Intestinal Gas Production

                            Details : Charcocaps is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Flatulence.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            August 22, 2022

                            Lead Product(s) : Charcocaps

                            Therapeutic Area : Gastroenterology

                            Highest Development Status : Undisclosed

                            Recipient : University of Memphis

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            DSE Healthcare Solutions

                            U.S.A arrow
                            SupplySide West
                            Not Confirmed

                            DSE Healthcare Solutions

                            U.S.A arrow
                            SupplySide West
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Paracetamol,Aspirin,Caffeine

                            Therapeutic Area : Neurology

                            Study Phase : Approved FDF

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            DSE Healthcare's VANQUISH Introduces Digital Headache Brand Pain Reliever For Modern Day Headaches

                            Details : DSE Healthcare Solutions recharges its legacy brand VANQUISH® to meet the needs of today's consumer with the launch of VANQUISH® DIGITAL HEADACHE™ Brand Pain Reliever.

                            Product Name : Vanquish

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            July 14, 2020

                            Lead Product(s) : Paracetamol,Aspirin,Caffeine

                            Therapeutic Area : Neurology

                            Highest Development Status : Approved FDF

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth